PTC Therapeutics
Patents, Design & Utilities
Last updated:
List of all PTC Therapeutics patents 95 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR DOSING AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)B- UTANAMIDE Filling date: 8 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Methods for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Methods for treating Huntington's disease Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: METHODS FOR MODIFYING RNA SPLICING Filling date: 8 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: FLUOROALKYL, FLUOROALKOXY, PHENOXY, HETEROARYLOXY, ALKOXY, AND AMINE 1,4-BENZOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: METHOD OF INHIBITING OR REDUCING A CORONAVIRIDAE VIRUS INFECTION Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)b- utanamide Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: COMPOSITIONS FOR AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR THE TREATMENT OF DISEASE Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: HYDROGEN ISOTOPE-ENRICHED ANALOGUES OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Grant | Utility: Methods for enriching alpha-tocotrienol from mixed tocol compositions Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 |
Application | Utility: DHODH INHIBITOR FOR USE IN TREATING HEMATOLOGIC CANCERS Filling date: 8 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: Treatment of pervasive developmental disorders with redox-active therapeutics Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders Filling date: 8 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Utility: Methods for modulating the amount of RNA transcripts Filling date: 8 Sep 2025 Issue date: 23 Jun 2020 |
Application | Utility: METHODS FOR TREATING EPILEPSY Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Grant | Utility: Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease Filling date: 8 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Methods for modulating RNA splicing Filling date: 8 Sep 2025 Issue date: 2 Jun 2020 |
Application | Utility: METHODS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: METHODS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: METHODS FOR TREATING HUNTINGTON'S DISEASE Filling date: 8 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Utility: Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Substituted pyridine and pyrazine BMI-1 inhibitors Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease Filling date: 8 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: SUBSTITUTED REVERSE PYRIMIDINE BMI-1 INHIBITORS Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES Filling date: 8 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Methods for treating epilepsy Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY Filling date: 8 Sep 2025 Issue date: 12 Dec 2019 |
Grant | Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Compounds for treating spinal muscular atrophy Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: METHODS FOR MODULATING RNA SPLICING Filling date: 8 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY Filling date: 8 Sep 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Substituted reverse pyrimidine Bmi-1 inhibitors Filling date: 8 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Substituted pyrimidine Bmi-1 inhibitors Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 |
Application | Utility: CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID FOR THE TREATMENT OF DISEASE Filling date: 8 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 95 of 95 patents.